Ying Xiong1, Qiang Zhang2, Yang Fan3, and Wenzhen Zhu1
1Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 2Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 3GE Healthcare, Beijing, China
Synopsis
This study aims to investigate brain microstructural changes
in white-matter and gray-matter of type 2 diabetes mellitus(T2DM) patients
using the NODDI model. Thirty-three T2DM patients were divided into two
sub-groups (impaired and normal cognition), together with ten healthy controls,
were imaged at a 3T scanner. It was found that the T2DM patients with cognitive
impairment had a lower ICVF value compared to healthy controls in WM regions
and the thalamus. Decreased ICVF values in the genu of corpus callosum were
correlated with HbA1c level. The NODDI model shows potential feasibility in
characterizing brain microstructural alterations for patients with T2DM.
Introduction/Purpose
The Type 2 diabetes mellitus (T2DM) is a
prevalent disease which has considerably higher risk of developing cognitive
impairment.1 Previous Diffusion Tensor Imaging (DTI) studies have
observed widespread white-matter (WM) integrity changes in several important
regions and the correlation with neuropsychological function.2,3 However,
although can provide sensitivity to tissue microstructures, DTI lacks
specificity for individual tissue microstructure features, such as neurite
density and orientation dispersions.4 Recently, a novel diffusion
MRI technique, termed NODDI (Neurite Orientation Dispersion and Density Imaging),
has been investigated to mapping the microstructural complexity of neurites. This
multi-compartment model separates the signal from extra- and intra-axonal
compartments in each voxel, and provides Intracellular Volume Fraction (ICVF)
and neurite Orientation Dispersion (Odi) estimates.4,5 It has been
widely used in neurological diseases.4-6 The purpose of this study is
to characterize brain microstructural alterations of T2DM patients with or
without cognitive impairment using the NODDI model.Methods
Subjects: With the approval of the
Institutional Review Board, 17 T2DM patients with cognitive impairment (DM-MCI
group), 16 age and gender matched T2DM patients with normal cognition (DM-NC
group), and 10 euglycemic healthy controls were enrolled in this study. The diagnostic
criteria of T2DM was based on American Diabetes Association. A battery of
neuropsychological tests (Montreal Cognitive Assessment, Mini-Mental State
Examination, Trail Making Tests,
Auditory Verbal Learning Test, Hachinski test, and Activity of Daily Living
test) were performed at first. The
inclusion criteria for the DM-MCI group were: 1) memory decline; 2) both
Montreal Cognitive Assessment and Mini-Mental State Examination scores ≤ 27. Plasma fasting/postprandial glucose and
Glycated hemoglobin A1c (HbA1c) were also recorded.
Imaging and data processing:
All MRI data were acquired on a 3 Tesla scanner (Discovery MR750, GE Health Care, Waukesha, Wisconsin, USA) equipped with
a 32-channel head coil. Axial common two-shell DWI images were obtained
for further NODDI analysis using a single-shot SE-EPI sequence with the
following parameters: TR/TE = 5000/98ms, FOV = 24×24cm
2, matrix size = 128×128, slice thickness = 4
mm, slice spacing = 0, slice number = 46, NEX = 1, two shells are b = 1250 and
2500 s/mm
2, diffusion encoding direction is 25 for each shell.
The ICVF and Odi maps were derived
using NODDI toolbox based on Matlab.
7 FMRIB Software Library with
tract-based spatial statistics (TBSS) was utilized to analyze the between-group
differences of ICVF and Odi within multiple white-matter (WM) regions.
ROI-based analysis was utilized to compare these metrics in bilateral thalamus
as a representative of gray-matter (GM) nucleus. The ICVF and Odi values of
bilateral thalamus and some WM regions (gene of corpus callosum and corona
radiata) were measured and averaged for further analysis using ImageJ. A series
of Mann-Whitney U-tests were used to assess the difference between each two groups.
Pearson’s correlation between ICVF value and disease duration/HbA1c level was
also performed. All statistical analysis procedures were conducted using SPSS
software (SPSS Inc., Chicago, IL).
Results
The
ICVF and Odi maps of typical subjects for each group were shown in Fig.1. Compared
with the healthy controls, the DM-MCI and DM-NC groups exhibited decreased ICVF
in 17.2% (23685/137832 voxels) and 1.5% (2013/137832 voxels) of WM regions respectively
(p<0.05). However, the angular variation of neurites, characterized by Odi,
exhibited no difference between either DM-MCI or DM-NC group and the controls (Fig.2).
The pronounced ICVF reduction occurred in the longitudinal fasciculus, corona
radiata, and corpus callosum. For GM analysis, ICVF also decreased in bilateral thalamus of
DM-MCI group when compared to the DM-NC/control groups (p<0.05 with a
Mann-Whitney U-test, Fig.3).
This can be related to the decreased density of axons and dendrites, or compromised
synapse in these WM regions and thalamus. The microstructural alternations and
network disruption are related with slower information processing speed and
cognition decline. Decreased ICVF values in the gene of corpus callosum were correlated with HbA1c level (with age as
covariate, R=-0.549, p<0.05, Fig.4).Discussion and Conclusions
The
reduced ICVF indicated decreased density of axons and dendrites in some
important WM regions and the thalamus in T2DM patients with cognitive decline. Such
indices of neurites relate more directly to and provide more specific markers
of brain tissue microstructure. Our results suggest that NODDI can probe
microstructural changes in WM and GM in patients with T2DM, and potentially
provide valuable information to study diabetic encephalopathy, including
cognitive impairment.Acknowledgements
No acknowledgement found.References
1. McCrimmon RJ, Ryan CM, Frier
BM: Diabetes and cognitive dysfunction. Lancet. 2012;379:2291-2299.
2. Hsu J-L, Chen YL, Leu JG,
et al. Microstructural white matter abnormalities in type 2 diabetes mellitus:
a diffusion tensor imaging study. Neuroimage. 2012;59(2):1098-1105.
3. Zhang J, Wang Y, Wang J, et
al. White Matter Integrity Disruptions Associated With Cognitive Impairments in
Type 2 Diabetic Patients. Diabetes. 2014;63(11):3596-3605.
4. Winston
GP. The potential role of novel diffusion imaging techniques in the
understanding and treatment of epilepsy. Quant Imaging Med
Surg. 2015;5(2):279-287.
5.
Churchill NW, Caverzasi E, Graham SJ, et al. White matter microstructure in athletes
with a history of concussion: Comparing diffusion tensor imaging (DTI) and
neurite orientation dispersion and density imaging (NODDI). Hum Brain Mapp.
2017;38(8):4201-4211.
6.
By S, Xu J, Box BA, et al. Application and evaluation of NODDI in the cervical
spinal cord of multiple sclerosis patients. Neuroimage Clin. 2017;15:333-342.
7. Hui Zhang,
Schneider T, Wheeler-Kingshott CA, et al. NODDI: practical in vivo neurite
orientation dispersion and density imaging of the human brain. Neuroimage,
2012;61(4):1000-1016.